MYDA Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,500
| Closed | -$167K | – | 132 |
|
|
2024
Q2 | $167K | Buy |
+12,500
| New | +$167K | 0.04% | 84 |
|
|
2022
Q4 | – | Sell |
-6,000
| Closed | -$749K | – | 81 |
|
|
2022
Q3 | $749K | Buy |
6,000
+750
| +14% | +$93.6K | 0.35% | 71 |
|
|
2022
Q2 | $500K | Buy |
5,250
+1,300
| +33% | +$124K | 0.14% | 97 |
|
|
2022
Q1 | $637K | Buy |
+3,950
| New | +$637K | 0.25% | 101 |
|
|
2021
Q4 | – | Sell |
-1,657
| Closed | -$768K | – | 260 |
|
|
2021
Q3 | $768K | Buy |
+1,657
| New | +$768K | 0.21% | 106 |
|